Additional file 15 of Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients



Additional file 15: Table S4. Overview of patient characteristics. ID, sex, categorisation, age of onset/diagnosis, and description of MCADD and control individuals from whom fibroblasts were taken.
Date made available4-Sept-2023

Keywords on Datasets

  • Medium-chain acyl-CoA dehydrogenase deficiency
  • Mitochondrial fatty acid oxidation
  • Personalised medicine
  • Metabolite partitioning
  • Kinetic modelling
  • Phenotypic heterogeneity
  • Inborn error of metabolism

Cite this